Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes.
Lucas Opazo-RiosYenniffer Sanchez MatusRaúl R Rodrigues-DíezDaniel CarpioAlejandra DroguettJesús EgidoCarmen Gomez-GuerreroSergio MezzanoPublished in: BMJ open diabetes research & care (2021)
Targeting SOCS proteins by mimetic peptides to control JAK/STAT signaling pathway ameliorates albuminuria, morphological renal lesions, inflammation, oxidative stress and lipotoxicity, and could be a therapeutic approach to T2D kidney disease.